September 14, 2012

The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

January 25, 2012

The National Advertising Review Board on Tuesday recommended that Novartis Consumer Health discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil.